Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Fatty Acyls
Glycerolipids
Glycerophospholipids
Saccharolipids
Sphingolipids
Displaying entries 1376 - 1400 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▼
Gangliosides LMSP0601AZ02
  • GalNAc-GM1b(d18:1/18:0)
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44262165 1748.956036 C81H144N4O36
Gangliosides LMSP0601BC02
  • GalNAc-GM1(d18:1/18:0)
  • GalNAcbeta1-4Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44262189 1748.956036 C81H144N4O36
Gangliosides LMSP0601BS02
  • GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44262317 1748.956036 C81H144N4O36
Gangliosides LMSP0601CO02
  • GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44262477 1748.956036 C81H144N4O36
Gangliosides LMSP0601CW02
  • NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44262541 1748.956036 C81H144N4O36
Gangliosides LMSP0601DP02
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44262669 1748.956036 C81H144N4O36
Gangliosides LMSP0601FD02
  • NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44262965 1748.956036 C81H144N4O36
Gangliosides LMSP0601FI02
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44263005 1748.956036 C81H144N4O36
Gangliosides LMSP0601FX02
  • NeuAcalpha2-3GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44263109 1748.956036 C81H144N4O36
Diacylglycerophosphoinositolglycans LMGP15010265
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(18:1(9Z)/18:1(9Z))
 126457633 1834.874083 C81H143O43P
Diacylglycerophosphoinositolglycans LMGP15010270
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(18:2(9Z,12Z)/18:0)
 126457638 1834.874083 C81H143O43P
Gangliosides LMSP0601AL02
  • GT3(d18:1/18:0)
  • NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44262053 1762.935301 C81H142N4O37
Diacylglycerophosphoinositolglycans LMGP15010271
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(18:2(9Z,12Z)/18:1(9Z))
 126457639 1832.858433 C81H141O43P
Gangliosides LMSP0601BK01
  • 9-OAc-NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44262252 1776.914566 C81H140N4O38
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AN06
  • Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
 44260273 1649.985544 C80H147NO33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AQ05
  • GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44260296 1662.980793 C80H146N2O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BF05
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44260416 1662.980793 C80H146N2O33
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BA05
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44261632 1662.980793 C80H146N2O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AI05
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • type IV H(d18:1/24:0)
 44260232 1646.985878 C80H146N2O32
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BM05
  • Fucalpha2-3Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44260472 1646.985878 C80H146N2O32
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AK05
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44260568 1646.985878 C80H146N2O32
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AE05
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • type I B antigen(d18:1/24:0)
 44260648 1646.985878 C80H146N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AE05
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • type II B antigen(d18:1/24:0)
 44261008 1646.985878 C80H146N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CV05
  • Gala 1-3Lex(d18:1/24:0)
  • Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44261552 1646.985878 C80H146N2O32
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AW05
  • Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44261616 1646.985878 C80H146N2O32
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback

Click here to visit the beta site.

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.0.0

Last updated: August 19, 2024